Skip to content

MIRM

Mirum Pharmaceuticals, Inc.

Stock

$82.93−0.99 (−1.18%)Close Oct 2, 2026

Net income, 2025
−$23M

Net income

Net income by fiscal year

PeriodNet incomeYoY
2025−$23M—
2024−$88M—
2023−$163M—
2022−$136M—
2021−$84M—
2020−$103M—
2019−$53M—